Term Sheet Template
📊 Document Completion Progress
⚖️ Legal Disclaimer
Important: This term sheet template is for informational purposes only and does not constitute legal advice.
Professional Review Required: Always have this document reviewed by a qualified securities attorney before execution.
Securities Law Compliance: Ensure compliance with applicable securities laws and regulations.
Investment Risk: Term sheets involve complex investment terms that require professional legal guidance.
TERM SHEET
Series A Preferred Stock Financing
[COMPANY NAME]
Investment Amount: $[Investment Amount]
Closing Date: December 15, 2025
Location: [City, State]
1. COMPANY INFORMATION
| Company: | [Company Name], a [State] corporation |
| Business Description: | [Description of company's business, products, and services] |
| Incorporation Date: | [Date of Incorporation] |
| Target Closing Date: | [Target Closing Date] |
2. INVESTMENT PARTIES
| Lead Investor: | [Lead Investor Name and Entity Type] |
| Co-Investors: | [List of other participating investors] |
| Total Investment Amount: | $[Investment Amount] |
3. INVESTMENT TERMS & VALUATION
| Security Type: | Series A Preferred Stock ("Series A Preferred") |
| Total Investment Amount: | $[Total Investment Amount] |
| Pre-Money Valuation: | $[Pre-Money Valuation] |
| Post-Money Valuation: | $[Post-Money Valuation] |
| Price Per Share: | $[Price Per Share] |
| Number of Shares Issued: | [Number of Shares] shares of Series A Preferred |
| Investor Ownership %: | [Ownership Percentage]% |
4. CAPITALIZATION TABLE
| Common Stock (pre-financing): | [Number of Common Shares] shares |
| Series A Preferred Stock: | [Number of Series A Shares] shares |
| Employee Option Pool: | [Option Pool Percentage]% of post-financing shares reserved |
| Fully Diluted Shares: | [Total Fully Diluted Shares] shares |
5. RIGHTS AND PREFERENCES
Dividend Provisions:
Series A Preferred will be entitled to receive dividends at the rate of [Dividend Rate]% of the original purchase price per annum, when and if declared by the Board of Directors.
Liquidation Preference:
In the event of any liquidation, dissolution, or winding up of the Company, the Series A Preferred will receive a liquidation preference of [1x-3x] times the original purchase price plus declared but unpaid dividends.
Conversion Rights:
Each share of Series A Preferred is convertible at the option of the holder into one share of Common Stock, subject to adjustment for stock splits, stock dividends, and similar events.
Anti-Dilution Provisions:
Series A Preferred will have [weighted average/full ratchet] anti-dilution protection in the event of future issuances at a lower price.
6. VOTING RIGHTS & GOVERNANCE
Series A Preferred will vote together with Common Stock on an as-converted basis, except for certain matters requiring separate class approval.
Board of Directors:
| Board Composition: | [Number of Directors] member board |
| Investor Directors: | [Number] directors designated by Series A Preferred holders |
| Common Directors: | [Number] directors designated by Common Stock holders |
| Independent Director: | [Number] independent director(s) mutually agreed upon |
7. PROTECTIVE PROVISIONS
So long as at least [Threshold Percentage]% of the Series A Preferred remains outstanding, consent of the Series A Preferred holders will be required for:
- Any amendment to the Company's charter or bylaws
- Issuance of equity securities (subject to exceptions)
- Incurrence of debt exceeding $[Debt Threshold Amount]
- Sale, lease, or licensing of material assets
- Approval of annual budget and business plan
- Changes to the size or composition of the Board
- Payment of dividends on Common Stock
- [Additional Protective Provisions]
8. INFORMATION RIGHTS
The Company will provide investors with standard information rights including:
- Monthly financial statements within [Number] days of month end
- Annual financial statements (audited) within [Number] days of year end
- Annual budget and business plan at least [Number] days before fiscal year end
- Reasonable access to Company books and records during business hours
- [Additional Information Rights]
9. REGISTRATION RIGHTS
| Demand Registration: | [Number] demand registration rights |
| Piggyback Registration: | Standard piggyback registration rights on all public offerings |
| S-3 Registration: | Unlimited S-3 registration rights (if available and applicable) |
| Registration Expenses: | Company bears all registration expenses (except underwriting discounts and commissions) |
10. TRANSFER RIGHTS
Drag-Along Rights:
Standard drag-along rights in favor of investors and management for any sale of the Company approved by [Threshold Percentage]% of the Series A holders.
Tag-Along Rights:
Standard tag-along rights in favor of investors for any sale of Common Stock by founders or management exceeding [Threshold Amount] shares.
Right of First Refusal:
Investors will have a right of first refusal on future equity financings of the Company, pro rata to their ownership percentage.
11. EMPLOYEE STOCK OPTION PLAN
| Option Pool Size: | [Pool Percentage]% of post-financing Common Stock on a fully diluted basis |
| Vesting Schedule: | Standard [Vesting Period]-year vesting with [Cliff Period]-year cliff for all employees |
| Acceleration Provisions: | [Single/Double]-trigger acceleration for key employees upon change of control |
| Exercise Period: | [Exercise Period] days post-termination for vested options |
12. CONDITIONS PRECEDENT TO CLOSING
- Completion of legal, financial, and business due diligence to investors' satisfaction
- Execution of definitive financing documents acceptable to all parties
- Board of Directors approval and requisite stockholder approval
- Updated Articles of Incorporation and Amended Bylaws
- Employment agreements with key management personnel
- Investor rights agreement and voting agreement
- Opinion of Company counsel regarding corporate matters
- Insurance policies as reasonably required by investors
- [Additional Closing Conditions]
13. LEGAL EXPENSES & FEES
The Company will bear its own legal and other transaction expenses, and will reimburse investors' reasonable legal expenses up to $[Legal Expense Cap].
14. CONFIDENTIALITY & BINDING PROVISIONS
This term sheet and all related discussions are confidential and proprietary. This term sheet is non-binding except for the confidentiality, exclusivity, and expense reimbursement provisions contained herein.
15. EXCLUSIVITY & EXPIRATION
The Company agrees to work exclusively with the investors for a period of [Exclusivity Period] days from the date hereof. This term sheet expires on [Expiration Date] if not accepted by that date.
SIGNATURES
COMPANY:
[CEO Name]
Chief Executive Officer
[Company Name]
Date: November 5, 2025
LEAD INVESTOR:
[Investor Name]
[Title]
[Investor Entity]
Date: November 5, 2025